Article Figures & Tables
Figures
- Figure 1:
Annual incidence of cannabinoid users in Manitoba, 2004/05–2014/15.
- Figure 2:
Annual incidence rate of cannabinoid use by age group (A), sex (B) and area of residence (C).
- Figure 3:
Annual prevalence of cannabinoid use.
Tables
- Table 1:
Demographic characteristics of new cannabinoid users in Manitoba, 2004/05 to 2014/15
Characteristic No. (%) of users
n = 5033Age group, yr ≤ 18 55 (1.1) 19–45 1698 (33.7) 46–64 2455 (48.8) ≥ 65 825 (16.4) Sex Female 2934 (58.3) Male 2099 (41.7) Area of residence Urban 3207 (63.7) Rural 1826 (36.3) Socioeconomic status High 458 (9.1) Middle 1712 (34.0) Mid-low 2028 (40.3) Low 835 (16.6) Medical condition* Chronic pain 2540 (50.5) Fibromyalgia 1775 (35.3) Mood/anxiety disorder 1116 (22.2) Cancer 917 (18.2) Osteoarthritis 662 (13.2) Substance abuse 418 (8.3) Multiple sclerosis 213 (4.2) Glaucoma 169 (3.4) Rheumatoid arthritis 155 (3.1) HIV/AIDS 51 (1.0) Schizophrenia 29 (0.6) Epilepsy 27 (0.5) ↵* Some users had more than 1 condition.
- Table 2:
Effect of time and sociodemographic characteristics on the prevalence and incidence of cannabinoid use in Manitoba, 2004/05–2014/15
Variable Relative rate (95% CI) Prevalence Incidence Change in annual rate 1.15 (1.14–1.16) 1.09 (1.08–1.10) Female v. male sex 1.38 (1.30–1.46) 1.33 (1.23–1.42) Age ≤ 18 v. ≥ 65 0.03 (0.02–0.04) 0.04 (0.03–0.06) 19–45 v. ≥ 65 0.96 (0.88–1.06) 0.82 (0.74–0.91) 46–64 v. ≥ 65 2.28 (2.09–2.49) 1.70 (1.53–1.89) Urban v. rural residence 1.17 (1.10–1.24) 1.11 (1.04–1.19) Socioeconomic status Low v. high 0.62 (0.55–0.71) 0.79 (0.68–0.92) Mid-low v. high 0.73 (0.66–0.80) 0.84 (0.74–0.95) Middle v. high 0.92 (0.89–1.08) 1.06 (0.94–1.19) Note: CI = confidence interval.
In this issue
Article tools
Respond to this article
Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study
Related Articles
Cited By...
- No citing articles found.